{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:36:40Z","timestamp":1787009800633,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5,12]]},"DOI":"10.1097\/01.npr.0000444656.40636.00","type":"journal-article","created":{"date-parts":[[2014,4,16]],"date-time":"2014-04-16T12:00:23Z","timestamp":1397649623000},"page":"8-11","source":"Crossref","is-referenced-by-count":4,"title":["Putting onychomycosis under the microscope"],"prefix":"10.1097","volume":"39","author":[{"given":"Tiffany T.","family":"Mayo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Cantrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"2","key":"R1-2-20210130","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/CMR.8.2.240","article-title":"The dermatophytes.","volume":"8","author":"Weitzman","year":"1995","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"R2-2-20210130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00128071-200001010-00002","article-title":"Onychomycosis. Treatment, quality of life, and economic issues.","volume":"1","author":"Elewski","year":"2000","journal-title":"Am J Clin Dermatol"},{"issue":"9","key":"R3-2-20210130","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/archderm.1997.03890450124022","article-title":"Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions.","volume":"133","author":"Elewski","year":"1997","journal-title":"Arch Dermatol"},{"issue":"5","key":"R4-2-20210130","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2710.2009.01107.x","article-title":"Toenail onychomycosis: an important global disease burden.","volume":"35","author":"Thomas","year":"2010","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"R5-2-20210130","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2165\/00128071-200910040-00001","article-title":"Toenail onychomycosis in diabetic patients: issues and management.","volume":"10","author":"Mayser","year":"2009","journal-title":"Am J Clin Dermatol"},{"issue":"10","key":"R6-2-20210130","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1046\/j.1365-4362.2000.00012.x","article-title":"Epidemiology and prevalence of onychomycosis in HIV-positive individuals.","volume":"39","author":"Gupta","year":"2000","journal-title":"Int J Dermatol"},{"issue":"3","key":"R7-2-20210130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4103\/0378-6323.95440","article-title":"Onychomycosis: newer insights in pathogenesis and diagnosis.","volume":"78","author":"Grover","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"R8-2-20210130","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1067\/mjd.2000.107754","article-title":"A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns.","volume":"43","author":"Ghannoum","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"R9-2-20210130","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1046\/j.1365-2133.1998.02449.x","article-title":"A new classification of onychomycosis.","volume":"139","author":"Baran","year":"1998","journal-title":"Br J Dermatol"},{"issue":"20","key":"R10-2-20210130","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1056\/NEJMcp0804878","article-title":"Clinical practice. Fungal nail disease.","volume":"360","author":"de Berker","year":"2009","journal-title":"N Engl J Med"},{"issue":"suppl 2","key":"R11-2-20210130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1365-4362.1999.00015.x","article-title":"The scope of onychomycosis: epidemiology and clinical features.","volume":"38","author":"Haneke","year":"1999","journal-title":"Int J Dermatol"},{"issue":"3","key":"R12-2-20210130","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/CMR.11.3.415","article-title":"Onychomycosis: pathogenesis, diagnosis, and management.","volume":"11","author":"Elewski","year":"1998","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"R13-2-20210130","first-page":"237","article-title":"Molecular analysis of dermatophytes suggests spread of infection among household members.","volume":"91","author":"Ghannoum","year":"2013","journal-title":"Cutis"},{"issue":"4","key":"R14-2-20210130","first-page":"663","article-title":"Treating onychomycosis.","volume":"63","author":"Rodgers","year":"2001","journal-title":"Am Fam Physician"},{"issue":"5","key":"R15-2-20210130","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.clindermatol.2013.06.009","article-title":"Diagnosing onychomycosis.","volume":"31","author":"Gupta","year":"2013","journal-title":"Clin Dermatol"},{"issue":"6","key":"R16-2-20210130","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jaad.2006.12.019","article-title":"Onychomycosis: diagnosis and definition of cure.","volume":"56","author":"Scher","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"R20-2-20210130","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.det.2007.01.002","article-title":"Advances in topical and systemic antifungals.","volume":"25","author":"Zhang","year":"2007","journal-title":"Dermatol Clin"},{"issue":"4","key":"R21-2-20210130","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jaad.2012.10.013","article-title":"Efinaconazole 10 solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies.","volume":"68","author":"Elewski","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"R22-2-20210130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1468-3083.2011.04373.x","article-title":"Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis: results from three randomized studies using double-blind vehicle-controlled and open-label active-controlled designs.","volume":"27","author":"Elewski","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"R23-2-20210130","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.clindermatol.2013.06.011","article-title":"Therapies for the treatment of onychomycosis.","volume":"31","author":"Gupta","year":"2013","journal-title":"Clin Dermatol"},{"issue":"3","key":"R24-2-20210130","first-page":"302","article-title":"The use of terbinafine in the treatment of onychomycosis in adults and special populations: a review of the evidence.","volume":"4","author":"Gupta","year":"2005","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"R25-2-20210130","doi-asserted-by":"crossref","first-page":"e679","DOI":"10.1111\/j.1439-0507.2011.02038.x","article-title":"Recent updates in oral terbinafine: its use in onychomycosis and tinea capitis in the US.","volume":"54","author":"Van Duyn Graham","year":"2011","journal-title":"Mycoses"},{"issue":"4","key":"R26-2-20210130","first-page":"299","article-title":"Safety and tolerability of oral antifungal agents in the treatment of fungal nail disease: a proven reality.","volume":"1","author":"Elewski","year":"2005","journal-title":"Ther Clin Risk Manag"},{"issue":"10","key":"R28-2-20210130","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1345\/aph.1M165","article-title":"Efficacy of fluconazole for the treatment of onychomycosis.","volume":"43","author":"Brown","year":"2009","journal-title":"Ann Pharmacother"},{"issue":"1","key":"R29-2-20210130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/14764172.2011.552616","article-title":"Laser treatment of onychomycosis using a novel 0.65-millisecond pulsed Nd:YAG 1064-nm laser.","volume":"13","author":"Hochman","year":"2011","journal-title":"J Cosmet Laser Ther"},{"issue":"4","key":"R30-2-20210130","first-page":"496","article-title":"Treating onychomycoses of the toenail: clinical efficacy of the sub-millisecond 1,064 nm Nd: YAG laser using a 5 mm spot diameter.","volume":"11","author":"Kimura","year":"2012","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"R31-2-20210130","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jaad.2013.04.054","article-title":"Treatment of onychomycosis using a submillisecond 1064-nm neodymium:yttrium-aluminum-garnet laser.","volume":"69","author":"Carney","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"R32-2-20210130","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/09546634.2012.714456","article-title":"Ozone gas effectively kills laboratory strains of Trichophyton rubrum and Trichophyton mentagrophytes using an in vitro test system.","volume":"25","author":"Gupta","year":"2014","journal-title":"J Dermatolog Treat"}],"container-title":["The Nurse Practitioner"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.NPR.0000444656.40636.00","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T15:20:44Z","timestamp":1620919244000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006205-201405000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,12]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/01.npr.0000444656.40636.00","relation":{},"ISSN":["0361-1817"],"issn-type":[{"value":"0361-1817","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5,12]]}}}